196 related articles for article (PubMed ID: 33130754)
21. [A Case of Locally Advanced Rectal Cancer Treated by Robot Assisted Intersphincteric Resection after Neoadjuvant Chemotherapy].
Kusafuka H; Kagawa Y; Kawai K; Hata T; Imada A; Sakamoto T; Murakami K; Katsura Y; Omura Y; Masuzawa T; Takeno A; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2021 Jan; 48(1):145-147. PubMed ID: 33468749
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study.
Hanna DL; Loupakis F; Yang D; Cremolini C; Schirripa M; Li M; Matsusaka S; Berger MD; Miyamoto Y; Zhang W; Ning Y; Antoniotti C; Salvatore L; Moran M; Zeger G; Astrow SH; Falcone A; Lenz HJ
Clin Colorectal Cancer; 2018 Sep; 17(3):e471-e488. PubMed ID: 29636300
[TBL] [Abstract][Full Text] [Related]
23. [A case of advanced colon cancer successfully treated with combination therapy of cetuximab and oxaliplatin, leucovorin, and 5-fluorouracil].
Ojima E; Nakano T; Kanamoto A; Sasaki S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1962-4. PubMed ID: 24393980
[TBL] [Abstract][Full Text] [Related]
24. [Pancreatoduodenectomy for locally advanced ascending colon cancer after neoadjuvant chemotherapy (mFOLFOX6)].
Oono R; Enomoto N; Hosoya N; Ueda Y; Otsuki S; Motoyama K
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1529-31. PubMed ID: 21918356
[TBL] [Abstract][Full Text] [Related]
25. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Fruth B; Meyerhardt JA; Schrag D; Greene C; O'Neil BH; Atkins JN; Berry S; Polite BN; O'Reilly EM; Goldberg RM; Hochster HS; Schilsky RL; Bertagnolli MM; El-Khoueiry AB; Watson P; Benson AB; Mulkerin DL; Mayer RJ; Blanke C
JAMA; 2017 Jun; 317(23):2392-2401. PubMed ID: 28632865
[TBL] [Abstract][Full Text] [Related]
26. [A Case of Curative Resection after Neoadjuvant Chemotherapy for Locally-Advanced Sigmoid Colon Carcinoma with Urinary Bladder Invasion].
Sato Y; Kobayashi M; Karasawa H; Ichikawa H; Kajiwara T; Kohyama A; Watanabe K; Kamei T; Ohnuma S; Unno M
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1764-1766. PubMed ID: 35046323
[TBL] [Abstract][Full Text] [Related]
27. Multiple stage IV colorectal cancers in a patient who received multidisciplinary treatment, including chemotherapy and Japanese Kampo medicine: A case report.
Aomatsu N; Maeda K; Uchima Y; Matsutani S; Tsujio G; Miyamoto H; Okada T; Kurihara S; Nishii T; Tachimori A; Ikeda K; Takeuchi K
Neuropeptides; 2021 Aug; 88():102160. PubMed ID: 34004454
[TBL] [Abstract][Full Text] [Related]
28. [A Case of Chemotherapy with FOLFOXIRI plus Cetuximab for Liver Metastasis of Sigmoid Colon Cancer].
Saito A; Konishi K; Fukunaga M; Takiguchi N; Nakai S; Honda S; Yukimoto R; Okamoto A; Takeoka T; Matsuno H; Okada K; Ota H; Yokoyama S; Konishi M; Kobayashi K
Gan To Kagaku Ryoho; 2018 Mar; 45(3):507-509. PubMed ID: 29650920
[TBL] [Abstract][Full Text] [Related]
29. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.
Falcone A; Ricci S; Brunetti I; Pfanner E; Allegrini G; Barbara C; Crinò L; Benedetti G; Evangelista W; Fanchini L; Cortesi E; Picone V; Vitello S; Chiara S; Granetto C; Porcile G; Fioretto L; Orlandini C; Andreuccetti M; Masi G;
J Clin Oncol; 2007 May; 25(13):1670-6. PubMed ID: 17470860
[TBL] [Abstract][Full Text] [Related]
30. [Four Cases of Locally Advanced Colorectal Cancer Resected after Neoadjuvant Chemotherapy with mFOLFOX6 plus Bevacizumab].
Doi Y; Suzuki Y; Sugano N; Yamaoku K; Takata K; Matsuura H; Yoneyama K; Kameda Y; Rino Y; Masuda M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1414-1416. PubMed ID: 29394652
[TBL] [Abstract][Full Text] [Related]
31. [A Resected Case of Advanced Lower Rectal Cancer with Neoadjuvant Chemotherapy by FOLFOXIRI plus Cetuximab].
Yamada K; Ioka T; Suzuki N; Yoshida S; Tomochika S; Matsukuma S; Matsui H; Shindo Y; Tokumitsu Y; Watanabe Y; Iida M; Takeda S; Hazama S; Ueno T; Nagano H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2067-2069. PubMed ID: 35045495
[TBL] [Abstract][Full Text] [Related]
32. [A case of undifferentiated colon cancer responding to FOLFIRI therapy].
Fujiwara K; Nagayoshi Y; Nakahara C; Yamasaki T; Iwashita T
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1525-7. PubMed ID: 21918355
[TBL] [Abstract][Full Text] [Related]
33. [The chemotherapy with mFOLFOX6 for advanced colon cancer was effective for gastric cancer - a case report].
Shimoishi K; Muto Y; Asakage M; Yamada Y
Gan To Kagaku Ryoho; 2012 Jul; 39(7):1127-30. PubMed ID: 22790053
[TBL] [Abstract][Full Text] [Related]
34. [A Case of Locally Advanced Appendiceal Cancer with Radical Resection after CAPOX plus Bevacizumab].
Ueda M; Ikenaga M; Tanida T; Taguchi D; Ikegami M; Fukushima S; Yoshida S; Sekiguchi N; Koh M; Iede K; Tsuda Y; Nakashima S; Matsuyama J; Yasui M; Yamada T
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1762-1764. PubMed ID: 33468821
[TBL] [Abstract][Full Text] [Related]
35. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
36. [A Case of Complete Pathological Response in a Patient with Locally Advanced Sigmoid Colon Cancer after FOLFOX IRI Chemotherapy].
Goto M; Okitsu H; Yuasa Y; Matsuo Y; Edagawa H; Tani R; Mori O; Kuramoto S; Tomibayashi A; Yamashita M; Fujii Y
Gan To Kagaku Ryoho; 2015 Nov; 42(11):1431-4. PubMed ID: 26602406
[TBL] [Abstract][Full Text] [Related]
37. [A case of drug-induced lung injury associated with chemotherapy (FOLFOX6, FOLFIRI, Bevacizumab) for an advanced colon cancer].
Komaki C; Hanatate F; Kobayashi K
Gan To Kagaku Ryoho; 2011 Jan; 38(1):113-6. PubMed ID: 21368470
[TBL] [Abstract][Full Text] [Related]
38. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
[TBL] [Abstract][Full Text] [Related]
39. [A case of advanced colon cancer with peritoneal dissemination effectively treated with modified FOLFOX6 chemotherapy].
Tanaka K; Hirai K; Ogawa H; Toya H; Totsuka O; Yoshinari D; Sunose Y; Takeyoshi I
Gan To Kagaku Ryoho; 2012 Jun; 39(6):993-5. PubMed ID: 22705700
[TBL] [Abstract][Full Text] [Related]
40. [A successfully resected case of colorectal cancer with multiple liver metastases treated with FOLFIRI after failure of mFOLFOX6].
Fukuda H; Tazawa K; Sawada S; Nagata T; Uotani H; Hirokawa S; Yamagishi F; Tsukada K
Gan To Kagaku Ryoho; 2008 Mar; 35(3):507-9. PubMed ID: 18347406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
